Sexual functioning of people with rheumatoid arthritis:a multicenter study by van Berlo, W.T.M. et al.
  
 University of Groningen
Sexual functioning of people with rheumatoid arthritis






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2007
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
van Berlo, W. T. M., van de Wiel, H. B. M., Taal, E., Rasker, J. J., Schultz, W. C. M. W., & van Rijswijk, M.
H. (2007). Sexual functioning of people with rheumatoid arthritis: a multicenter study. Clinical
Rheumatology, 26(1), 30-38. https://doi.org/10.1007/s10067-006-0216-3
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Clin Rheumatol (2007) 26: 30–38
DOI 10.1007/s10067-006-0216-3
ORIGINAL ARTICLE
Willy T. M. van Berlo . Harry B. M. van de Wiel .
Erik Taal . Johannes J. Rasker .
Willibrord C. M. Weijmar Schultz .
Martin H. van Rijswijk
Sexual functioning of people with rheumatoid arthritis:
a multicenter study
Received: 23 November 2005 / Revised: 12 January 2006 / Accepted: 12 January 2006 / Published online: 1 March 2006
# Clinical Rheumatology 2006
Abstract The objective of this study is to compare men
and women with rheumatoid arthritis (RA) to controls
regarding sexual motivation, activity, satisfaction, and
specific sexual problems, and to determine the correlation
of physical aspects of the disease with sexual functioning.
Questionnaire for screening sexual dysfunctions (QSD),
self-constructed questionnaire on experienced distress with
joints during sexual activities, arthritis impact measure-
ments scales 2 (AIMS2), and the modified disease activity
score 28 (DAS 28) were the methods used. RA patients
were recruited from a registration base in three Dutch
hospitals. Controls were age and sex matched healthy
volunteers. A completed questionnaire was sent back by
271 patients (response 23%). Forty-seven men and 93
women were clinically examined to obtain the DAS 28.
Male patients felt less sexual desire, and female patients
masturbated and fantasized less than controls. Differences
in satisfaction were not found. Male and female patients
did not experience more sexual problems than controls.
Among the women, correlations were predominantly found
between age and sexual motivation and activities, among
the men between physical health and sexual problems. Up
to 41% of the men (4–41 depending on the joints), and up
to 51% of the women (10–51 depending on the joints) have
troubles with several joints during sexual activities.
Medications influencing ejaculation in men correlated
with distress with orgasm. Conclusions are that patients are
less sexually active than controls and a considerable
number of both male and female patients have trouble with
their joints during sexual activities. However, patients do
not differ from controls regarding sexual satisfaction.
Physiological changes due to RA are apparently indepen-
dent from those on psychological level. It is argued that
sexual satisfaction also depends on personal and social
factors. In men, physical health and disease activity are
more related with sexual problems than in women.
Keywords Rheumatoid arthritis . Sexual functioning .
Sexual problems . Sexual satisfaction
Introduction
For a variety of reasons, it may be assumed that rheumatoid
arthritis (RA) influences sexual functioning. People with
RA suffer from pain, restricted joint movements, and
fatigue, and they can have problems with self-esteem and
body image. It is also possible that medication causes
sexual problems. Research on the subject is limited, and
shows a divergent picture (see Van Berlo et al. [1] for a
literature review.) The percentage of arthritic patients who
experience sexual problems ranged in these studies from 31
to 76% [2–8]. Sexual problems, however, were defined in
different ways: from not specified “sexual difficulties” [2]
to specific forms of sexual dysfunction. These are therefore
made operational in different ways. In most studies,
(structured) interviews or self-constructed self-report
questionnaires have been used. Moreover, studies differed
considerably in method, with only a few using healthy
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controls [3, 9–13]. In many studies, the rheumatic diseases
were not specified.
In this study, the influence of rheumatoid arthritis on
sexual functioning has been investigated. A standardized,
validated instrument to measure sexual functioning (see
also Quaresma et al. [14]) and a healthy control group were
included. Heterosexual and homosexual patients were
distinguished.
The aims of the study were:
1) To evaluate sexual motivation, sexual activity, and
sexual satisfaction among men and women with
rheumatoid arthritis.
2) To establish problems in sexual contact with the
partner.
3) To compare sexual functioning of people with RA to
the sexual functioning of healthy controls.




Patients with RAwere recruited from the standard diagnosis
registration [15] of the departments of rheumatology in
three hospitals: the Medisch Spectrum Twente Hospital in
Enschede (a large regional hospital), the university hospital
in Groningen, and the Wilhelmina Hospital in Assen
(a small hospital serving mainly a rural area). Inclusion
criteria for participating were: (1) RA according to the
American College of Rheumatology criteria [16] and/or
Sjögren’s Syndrome [17], (2) age 18 years and older, and
(3) sufficient knowledge of the Dutch language to complete
a self-report questionnaire. All patients who met the criteria
received a form on which they could indicate their
willingness to participate. If so, they received a package
including all questionnaires by mail. No reminders were
sent. All patients were also invited to come to the hospital
for a clinical examination by a research nurse.
The control group consisted of a convenience sample of
107 healthy volunteers. They were a subgroup of a larger
sample of volunteers, who were recruited using the
snowball method among acquaintances of the author of
the questionnaire for screening sexual dysfunctions (QSD)
(see below) and some other researchers in the Netherlands.
The subgroup was selected on the basis of age and sex.
Controls were only invited to participate if they did not
have a severe disease.
Measures
Sexual functioning
The short versions of the QSD [18] were used to measure
sexual functioning. The QSD is a multidimensional self-
report questionnaire with subscales addressing the fre-
quency of sexual problems and the experienced distress
with these problems. Formats for different kinds of sexual
relationships are available (i.e., for men and women with a
female partner, a male partner, and without a partner). In
this study, individual items of the QSD were used to
measure the frequency of desire for sexual contact, sexual
contact, masturbation, and sexual contact against the will
of the respondent. These frequencies are rated on seven-
point scales (1 = less than once per month, 7 = several times
a day). Subscales were used addressing both frequency and
experienced distress of several sexual problems and sexual
satisfaction [19]. Responses were rated on five-point scales
(1 = almost never, 5 = always; 1 = no distress, 5 = very
much distress; 1 = very dissatisfied, 5 = very satisfied). The
subscale “sexual satisfaction” consists of two items: “How
satisfied are you with your current sexual life?” and “How
satisfied are you with the sexual contact you have with your
partner?” The QSD is widely applied in research and
clinical practice in the Netherlands, but not yet in studies on
RA [20–24]. Research on the validity of this instrument is
available [25].
Sociodemographics
The QSD also contains information on sociodemographics,
i.e., age, marital status, length of relationship, and
educational level (1 = primary school, 7 = university).
Physical function and pain
Physical function and pain were assessed with the Dutch-
AIMS2 (Arthritis Impact Measurement Scales), a self-
report questionnaire [26, 27]. The AIMS2 includes scales to
measure physical function (scales for mobility, walking and
bending, hand and finger function, arm function, self-care,
and household tasks), and one scale to measure pain. The
scores per scale range from 0 (good health) to 10 (poor
health). The physical dimension score was computed by
averaging the scores of the contributing scales. A self-
constructed questionnaire was used to measure experienced
distress with seven joints during sexual activities. The
scores range from 1 (very much distress) to 5 (no distress).
Comorbidity
Comorbidity was also assessed with the AIMS2. Ten
comorbidities were listed explicitly to be checked where
applicable. Respondents could also check “other comor-
bidities” and describe these themselves.
Disease activity
Patients were clinically examined by two research nurses in
the hospitals of Groningen and Enschede to assess disease
activity. The modified disease activity score (DAS 28) is an
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index of disease activity [28, 29]. It includes (1) a joint
index of 28 joints evaluated for tenderness and swelling,
(2) erythrocyte sedimentation rate (ESR), and (3) general
health assessment scored on a visual analogue scale (VAS).
The higher the score, the more active the disease.
Use of medication
In the AIMS2 Questionnaire an extra question was
included regarding medication intake. Medications were
divided in (1) drugs specifically prescribed for RA or often
taken together with RA medication such as H2 blockers,
protonpump inhibitors, and antihypertensive drugs, (2)
drugs for other indications, and (3) psychopharmaceuta.
The effect of these medications on sexual functioning—as
far as known from literature—were scored, i.e., the effect
on libido, erection, and orgasm/ejaculation with regard to
men, and on libido, lubrication and orgasm with regard to
women [30, 31].
Statistical analysis
Data analysis was performed using SPSS-PC software
(version 11.0). Analyses included descriptive statistics, chi-
square tests, t tests, analysis of variance (ANOVA) with
Bonferroni post hoc test, and analysis of covariance
(ANCOVA) with educational level as a covariate because
controls were significantly higher educated than patients.
When variables were not normally distributed, the non-
parametric Mann–Whitney U test was performed, as well
as Spearman correlations. p values<0.05 were considered
significant.
Ethics
The ethical committees of the three participating hospitals
approved of the study.
Results
Response
A total of 1,196 people with RA and/or Sjögren’s
syndrome were invited to participate in the study by
means of a reply form. A completed questionnaire was sent
back by 271 patients, 243 with RA and 28 with either
Sjögren’s syndrome (n=3) or Sjögren’s syndrome and RA.
The response was 23%. The reply form was returned by
261 people with RAwho refused to participate in the study,
this is 22% of those invited. Although one needs to be
careful in making generalizations, we compared the
refusers and nonresponders with those who agreed to
participate (Table 1).
There were no differences in sex between the three
groups, nor between the participants and those who either
refused or did not respond (n=925). Among the men, no
differences in age were found between the three groups and
between the participants and all refusers. Among the
women, those who refused were significantly older than the
participating women and the nonresponding women, and
also, refusing and nonresponding women were signifi-
cantly older than the participating women. The percentage
of patients without a partner was also higher among those
who refused.
Twenty-seven women and three men reported not having
a partner. Because the number of single men was too small,
Table 1 Response percentages and demographic characteristics of participants, refusers, and nonresponders

















Sexc (%) 30 70 23 77 31 69 28 72
Age
[mean(SD)]d
57.4 (11.3) 53.6 (12.7) 59.5 (12.6) 59.1 (13.3) 55.9 (12.8) 55.8 (14.2) 56.7 (12.8) 56.8 (14.0)
Partner
Male (%) – 84 – 78 unknown unknown unknown unknown
Female (%) 96 (1)e 74 –
No (%) 4 16 26 22
aSixteen refusers did not indicate their gender
bWe do not know how many of the nonresponders had RA and how many Sjögren’s syndrome, and also how many of them had a partner.
From 53 individuals we did not know the gender. No data are available about the mean age of the patients from Assen who did not
respond; the mean age mentioned is from patients from the other two hospitals
cDifferences in sex between the groups were tested with chi2 tests, and were not significant
dDifferences in age were tested with ANOVA and the Bonferroni post hoc test. Differences between the men in the three
groups were not significant. Women in the refusing group were significantly older than the women in the response group (p=0.000)
and the women in the nonresponse group (p<0.05). When refusers and nonresponders were taken together and compared with the
participants, differences in sex were also not found. Differences in age among the men were also not found; nonresponding
and refusing women were significantly older than the participating women (p<0.01)
eOnly one female patient reported to have a homosexual relationship
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the data on patients without a partner were omitted. Only
one patient, a woman, was homosexual.
Forty-seven men and 93 women agreed to undergo a
clinical examination to obtain the DAS28.
In this article we are only reporting on people with RA
who have a partner of the opposite sex (n=213).
Sociodemographic and clinical characteristics
There is no statistical difference in age between male
patients and controls or between female patients and
controls. (Table 2) Male and female controls are sig-
nificantly higher educated than the male and female
patients, respectively.
Although patients with severe comorbidity were not
invited to participate, it appeared that 51% of the patients
had some kind of other health problem (as measured with
the AIMS2): Twenty-five percent had hypertension, 9%
heart problems, 5% diabetes, 4% cancer, 13% lung disease,
1% kidney disease, 1% liver disease, 8% stomach
problems, 1% blood disease, and 14% had other health
problems.
Patients from the three different hospitals did not differ
from each other regarding health status (as measured with
the AIMS2) and sexual problems (as measured with the
QSD).
Sexual functioning
Sexual desire, sexual activity, and satisfaction
with sexual life
Male and female patients, more often than controls, did not
feel any desire for sexual contact with their partner, did not
have sexual contact with their partner, did not masturbate,
and did not have sexual daydreams or fantasies. However,
female patients and controls did not differ significantly
regarding sexual contact with the partner. Both male and
female patients also differed significantly from controls
regarding the frequency of sexual activities, desire, and
fantasies.
Differences between male patients and controls regard-
ing frequency of sexual fantasies, sexual contact, and
masturbation were not significant after correction for
education. Among the women, differences between pa-
tients and controls were no longer significant regarding
frequency of sexual desire and sexual contact. Results are
summarized in Table 3.
Sexual problems
It appeared that patients, both men and women, did not
have more sexual problems than controls, and did not
experience more distress from these problems (Table 4).
On the contrary, when differences were found, controls
more often had problems and suffered more from these
problems, especially the women. However, both male and
female patients had significantly more often pain, and
suffered more from this pain, than controls.
Physical determinants of sexual functioning
Age, duration of disease, disease activity (DAS28),
physical function, and pain were considered as physical
determinants. It appeared that physical functioning and, to
a lesser extent, disease activity and duration of the disease
correlated with various sexual problems in men but not in
women (Tables 5 and 6). In women, correlations were
predominantly found between age and sexual motivation,
activity, and fantasies; the older the women, the less
motivation and activity.
To explore further on the influence of specific aspects of
the disease on sexuality, we asked the patients to what
extent they experienced distress with their joints during
several sexual activities (Table 7). A considerable number
of the patients, especially the women, experienced much to
very much distress with their joints during sexual activities.
Table 2 Sociodemographic and clinical characteristics of men and women with RA and healthy controls
Men Women
Patients (n=76) Controls (n=54) Patients (n=136) Controls (n=53)
mean (SD) mean (SD) t test mean (SD) mean (SD) t test
Age 57.6 (10.6) 54.9 (9.4) n.s. 52.7 (11.8) 49.4 (10.8) n.s.
Age partner 54.6 (11.2) 50.9 (11.4) n.s. 55.2 (11.9) 50.2 (12.4) p<0.05
Length relationship (in years) 31.0 (12.2) 25.8 (14.2) p<0.05 28.6 (13.9) 25.1 (12.5) n.s.
Education (1–7)a 3.4 (1.7) 5.4 (1.9) p=0.000 3.3 (1.7) 5.0 (1.7) p=0.000
Disease duration (in years) 13.1 (9.8) 13.8 (11.1) n.s.
Disease activity (DAS28) 3.50 (1.45) 4.25 (1.42) p<0.01
Physical function (0–10)b 2.08 (1.85) 2.39 (1.70) n.s.
Pain (0–10)b 4.36 (2.21) 4.92 (1.99) n.s.
a1 = elementary school, 7 = university
b0 = good health, 10 = poor health
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% % Chi2 test % % Chi2 test
Sexual daydreams/fantasies (yes) 65 89 p<0.01 37 68 p=0.000
Desire for sexual contact with partner (yes) 85 96 p<0.05 86 96 p<0.05
Sexual contact (yes) 82 94 p<0.05 90 98 n.s.
Masturbation (yes) 52 79 p<0.01 29 70 p=0.000
Sexual contact against will (yes) 1 4 n.s. 22 30 n.s.
Mean (SD) Mean (SD) t test Mean (SD) Mean (SD) t test
Frequency sexual daydreams/fantasies (1–7) 2.41 (1.51) 3.06 (1.50) p<0.05a 1.42 (.94) 1.94 (1.27) p<0.01b
Frequency desire for sexual contact with partner
(1–7)
3.21 (1.55) 4.10 (1.40) p<0.01 2.89 (1.44) 3.44 (1.34) p<0.05a
Frequency sexual contact (1–7) 2.83 (1.52) 3.51 (1.26) p<0.01a 3.22 (1.47) 3.74 (1.38) p<0.05a
Frequency masturbation (1–7) 1.84 (1.30) 2.43 (1.45) p<0.05a 1.24 (0.81) 1.77 (0.94) p=0.000b
Frequency sexual contact against will (1–7) 1.00 (0.00) 1.00 (0.00) – 1.15 (0.62) 1.08 (0.39) n.s.b
Sexual satisfaction (1–5) 3.56 (0.90) 3.58 (0.81) n.s. 3.69 (0.80) 3.73 (0.93) n.s.
an.s. after correction for education with ANCOVA
bNon-parametrically tested with Mann–Whitney U test, correction for education not possible










Mean (SD) Mean (SD) Mann–Whitney
U test
Mean (SD) Mean (SD) Mann–Whitney
U test
Frequency sexual problemsa
Erectile problems 1.50 (0.78) 1.49 (0.64) n.s.
Lubrication problems 1.44 (0.80) 1.67 (0.88) p<0.05
Sexual excitement problems 1.24 (0.37) 1.28 (0.37) n.s. 1.48 (0.73) 1.71 (0.78) p=0.01
Orgasm problems 1.24 (0.48) 1.29 (0.34) n.s. 1.72 (1.01) 2.03 (1.04) p<0.01
Ejaculation problems 1.29 (0.62) 1.26 (0.66) n.s.
Premature orgasm 1.33 (0.55) 1.53 (0.50) p<0.01 1.17 (0.33) 1.14 (0.35) n.s.
Genital pain 1.04 (0.26) 1.10 (0.36) n.s. 1.30 (0.64) 1.41 (0.64) n.s.
Genital insensitivity 1.03 (0.14) 1.12 (0.33) n.s. 1.14 (0.46) 1.25 (0.57) n.s.
Pain elsewhere 1.61 (0.99) 1.08 (0.39) p=0.000 1.56 (0.95) 1.09 (0.41) p=0.000
Negative emotions 1.02 (0.10) 1.07 (0.17) n.s. 1.05 (0.19) 1.11 (0.26) p<0.05
Experienced distress with sexual problemsb
Erectile problems 1.48 (0.74) 1.35 (0.58) n.s.
Lubrication problems 1.41 (0.72) 1.63 (0.80) p<0.05
Sexual excitement problems 1.35 (0.58) 1.26 (0.38) n.s. 1.39 (0.62) 1.66 (0.74) p<0.01
Orgasm problems 1.29 (0.53) 1.20 (0.40) n.s. 1.50 (0.74) 1.61 (0.61) p<0.05
Ejaculation problems 1.29 (0.63) 1.12 (0.28) n.s.
Premature orgasm 1.30 (0.59) 1.41 (0.50) p<0.05 1.10 (0.25) 1.05 (0.18) n.s.
Genital pain 1.06 (0.29) 1.15 (0.54) n.s. 1.39 (0.74) 1.47 (0.72) n.s.
Genital insensitivity 1.03 (0.17) 1.14 (0.39) p<0.05 1.11 (0.32) 1.20 (0.41) n.s.
Pain elsewhere 1.58 (0.97) 1.12 (0.48) p=0.000 1.60 (1.02) 1.09 (0.35) p=0.000
Negative emotions 1.05 (0.16) 1.11 (0.23) p<0.05 1.09 (0.34) 1.20 (0.47) n.s.
a1 = almost never; 5 = always
b1 = no distress; 5 = very much distress
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Use of medication
Almost all patients (men 97% and women 96%) were
taking medication (for RA, other diseases or psychophar-
maceuticals), irrespective of possible side effects for sexual
functioning. With regard to the control group, this is
unknown.
Of the male patients, 63% took medication for RA (or
medications prescribed for side effects) with a known effect
on the libido (e.g., indometacine, cimetidine, diclofenac-
Table 5 Significant Spearman correlations between physical aspects of the disease, pain and age, and sexual motivation, sexual activity,









Sexual motivation, sexual activity, and sexual
satisfaction
Frequency desire for sexual contact with
partner
−0.30**
Frequency sexual contact −0.35**
Frequency sexual problems
Erectile problems 0.25*
Sexual excitement problems 0.26*
Orgasm problems 0.35**
Ejaculation problems 0.29* 0.30* 0.31**
Pain elsewhere 0.30* 0.47**
Negative emotions 0.29* 0.26*
Experienced distress with sexual problems
Erectile problems 0.36**
Sexual excitement problems 0.38* 0.35**
Orgasm problems 0.39** 0.32**
Ejaculation problems 0.25* 0.34**
Pain elsewhere 0.35* 0.44**
Negative emotions 0.28* 0.33* 0.36** 0.27*
Variables with no significant correlations and nonsignificant correlations are not reported
*p<0.05
**p<0.01
Table 6 Significant Spearman correlations between physical aspects of the disease, pain and age, and sexual motivation, sexual activity,









Sexual motivation, sexual activity, and sexual
satisfaction
Frequency sexual daydreams/fantasies −0.31**
Frequency desire for sexual contact with
partner
−0.41**
Frequency sexual contact −0.33** −0.25** −0.22*
Frequency masturbation −0.32**
Frequency sexual contact against will
Sexual satisfaction −0.24* −0.21*
Frequency sexual problems
Pain elsewhere −0.24**
Experienced distress with sexual problems
Pain elsewhere −0.23**
Negative emotions −0.24**




misoprostol, naprosyne), 87% with a known effect on
erection (e.g., methotrexate, indometacine, sulphasalazine,
hydroxychloroquin), and 54% with a known effect on
ejaculation (e.g., methotrexate, naprosyne).
Among the women with RA, these percentages are quite
different. 1.5% used medication for RAwith a known effect
on the libido (e.g., cimetidine, medroxyprogesteron), 1.5%
with a known effect on lubrication (e.g., cimetidine), and
none of the women used RA medication with a known
effect on orgasm. It is important to mention that the
influence of medication on the sexual functioning of
women has hardly been investigated. Because the number
of women who used medication with a known effect is
negligible, the data of the women were not explored. With
regard to the men, a comparison was made between men
who used RA medication with a known effect and those
who did not. Differences concerning sexual activities
(sexual fantasies, masturbation, desire, and sexual contact)
were not found. With regard to frequency of and
experienced distress with sexual problems, men who
used medication with a known effect on ejaculation
experienced indeed more distress with orgasm than men
who did not use this medication [means (SD) resp. 1.39
(0.58) and 1.17 (.44), p<0.05 (non-parametrically tested).
Discussion
People with RA felt less desire for sexual contact with their
partner, had less sexual contact, masturbated less fre-
quently, and fantasized less frequently than healthy
controls. After correction for education, male patients
still felt less sexual desire than controls, and female patients
masturbated and fantasized less than female controls.
Differences in sexual dysfunctions were hardly found.
Regarding frequency of and experienced distress with
sexual problems, men and women with RA had even lesser
problems than controls. The fact that RA patients do not
differ from controls regarding sexual dysfunction may
indicate that a high percentage of a healthy population of
this age has sexual problems anyway. This, however, does
not mean that RA patients do not have problems during
sexual activities. A considerable percentage of the patients
indicated that they have trouble with their joints during
sexual activities.
We noticed a remarkable difference between men and
women with RA. Considering the correlations between
sexual problems and physical aspects, we see that physical
function and disease activity, and to a lesser extent duration
of the disease, played a far more conclusive role among the
men than among the women. For the women, physical
function, disease activity, and duration of the disease did
not have an influence on sexual problems whatsoever.
However, more women than men had trouble with their
joints during several sexual activities. This result may
confirm the idea that women generally place a different
value on sexuality than men, focusing more on social,
cultural, and emotional factors, while men are more
focused on their bodies [32, 33]. Another explanation
may be that men are supposed to have an active role in
sexual activities, and therefore have more physical
problems during sex.
Patients and controls did not differ regarding sexual
satisfaction, despite the fact that patients appeared to have
less sexual desire, were less sexually active, and had
considerable distress in the joints during sexual activities.
Physiological changes due to RA are apparently inde-
pendent from those on a psychological level. This has also
been found in other studies regarding the consequences of
disease on sexuality [19, 34, 35]. It seems that patients
adapt their conceptions when confronted with illness or
handicap, and other factors play a role regarding (the
satisfaction of) sexual life. Therefore, although direct
sequelae of the disease such as pain, fatigue, and stiffness
may interfere with sexual functioning (see also Hill et al.
[36]), an improved communication within the relationship,
better mutual understanding, and other priorities like
enjoyment of what is still possible, may compensate the
negative effects. In an earlier study, Rasker et al. [37] for
example found that a substantial number of people with RA
experience an improved relationship. Healthy people
weigh such negative and positive factors in their lives as
well. Healthy women, for example, attributed negative
influences on sexuality to busy jobs, young children, less
time in general, and conflicting sexual desire [19]. Thus,
Table 7 Rather much to very much distress with several joints






























changes in sexual functioning after the onset of a chronic
disease do not automatically lead to sexual problems.
Whether sexual dissatisfaction occurs will also depend on
personal factors, social factors, and the context in which
these (negative) changes occur [35, 38, 39].
A few comments on this study must be made. The first
concerns the low response. An explanation may be that
people with RA are relatively ill and rather old. They may
have other priorities than sexuality. The focus of the study
on sexuality may have made patients apprehensive. In such
cases the questions on sexuality were considered to be too
intimate, too detailed, and not relevant for their current
situation (see also Klee et al. [40]). They may also have
been reluctant to cooperate as they were also invited to
participate in a clinical investigation in the hospital. Due to
the low response, the results should be regarded with some
caution, as one could doubt the representativeness of the
sample. However, the results sustain current theoretical
notions on the topic of sex and disease [35], and are in line
with other studies in this field [19, 41]. Moreover, age and
sex of the participating patients did not differ much from
nonresponding patients, and are conform to what one
would expect (mean age between 55–60 years, proportion
male patients about 30%). The percentage of patients
without a partner was higher among those who refused.
This may explain why some did not want to cooperate, as
was in fact mentioned on several forms. They judged
themselves as inappropriate respondents as they did not
have a partner.
The second comment concerns the comparability of
the patients and the controls. The two groups differed
significantly on the level of education and after correction
for education some of the differences between patients
and controls regarding frequencies of sexual activities
disappeared.
Finally, except motivation, sexual activities and satisfac-
tion, the QSD measures specific sexual dysfunctions, such
as problems with arousal and orgasm. It may be questioned
whether a standard questionnaire regarding sexual func-
tioning is sufficient to study this aspect in RA patients. A
more specific questionnaire aiming at the specific aspects
of the disease may give a clearer picture.
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